The pandemic caused by the unexpected emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has prompted an urgent need for therapeutics and a vaccine against this infectious disease. Explore Cayman's tools to support the needed research to understand emerging infectious diseases in this issue of the Cayman Currents. 

Cayman Currents Issue 33: Antiviral Strategies for Emerging Infectious Diseases. In this issue:

  • Using Existing Therapeutics Against SARS-CoV-2
  • SARS-CoV-2 Research Tools
  • Antiviral Compounds & Libraries
  • Vaccine Development Considerations
  • Host Immune Response
  • Immunopeptidome Profiling Services
  • Special Feature: Viral Infection Life Cycle Infographic

Articles:

Click here to open '​Cayman Currents Issue 33: Antiviral Strategies for Emerging Infectious Diseases'. Request a physical copy here.

Click here to open 'Viral infection life cycle centerfold'